Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaomin Duan
Xiaomin Duan
Chinese Academy of Sciences
Internal medicine
Immunogenicity
Seroconversion
Antibody
Placebo
3
Papers
102
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.
2021
Nature Communications
Yanyun Du
Rui Shi
Ying Zhang
Xiaomin Duan
Li Li
Jing. Zhang
F. S. Wang
Ruixue Zhang
Hao Shen
Wang Yue
Zheng Wu
Qianwen Peng
Ting Pan
Wanwei Sun
Weijin Huang
Yue Feng
Hui Feng
Junyu Xiao
Wenjie Tan
Youchun Wang
Chenhui Wang
Jinghua Yan
Show All
Source
Cite
Save
Citations (1)
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
2021
Lancet Infectious Diseases
Shilong Yang
Yan Li
Lianpan Dai
Jianfeng Wang
Peng He
Changgui Li
Xin Fang
Chenfei Wang
Xiang Zhao
Enqi Huang
Changwei Wu
Zaixin Zhong
Fengze Wang
Xiaomin Duan
Siyu Tian
Lili Wu
Yan Liu
Yi Luo
Zhihai Chen
Fangjun Li
Junhua Li
Xian Yu
Hong Ren
Lihong Liu
Shufang Meng
Jinghua Yan
Zhongyu Hu
Lidong Gao
George F. Gao
Show All
Source
Cite
Save
Citations (80)
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
2020
medRxiv
Yang Shilong
Yan Li
Lianpan Dai
Jianfeng Wang
Peng He
Changgui Li
Xin Fang
Chenfei Wang
Xiang Zhao
Huang Enqi
Wu Changwei
Zaixin Zhong
Fengze Wang
Xiaomin Duan
Siyu Tian
Lili Wu
Yan Liu
Yi Luo
Zhihai Chen
Fangjun Li
Junhua Li
Xian Yu
Hong Ren
Lihong Liu
Shufang Meng
Jinghua Yan
Zhongyu Hu
Lidong Gao
George F. Gao
Show All
Source
Cite
Save
Citations (21)
1